...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Two big thank you’s

Taking a look at trading over the last year there is plenty of times that ZHCLF has traded at or below the current prices. January, June, July September and November. There is no need to stretch any imagination here to see what the market is valuing this stock at.

tada 

Share
New Message
Please login to post a reply